Atlas Trials

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

Clinical trial NCT01361412 · COMPLETED

Trial details

NCT number
NCT01361412
Sponsor
Circassia Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ragweed Allergy
Start date
2011-03-01
Primary completion
2011-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.